Go to industries

Private Equity

Critical guidance on your journey

In the increasingly competitive environment of private equity, great deals are harder to find and the exceptional risk becomes the rule. With deep expertise across many industries and 850+ professionals providing M&A, growth equity and ECM, debt advisory and corporate finance services globally, we deliver a deal flow consisting of the very best opportunities on the market — and help you gain the upper hand.

Contact advisor
Worldwide
717
deals closed in Private Equity
Worldwide
Explore all our industry-related deals
Go to deals
Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital
Private Equity | Healthcare

Ace Pharmaceuticals has been acquired by Gilde Buy Out Partners, Gilde Healthcare and Quadrum Capital

Ace Pharmaceuticals BV has been acquired by Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and the management team.

Learn more
Leadec has acquired Diversified Automation
Private Equity | Industrial Machinery & Components

Leadec has acquired Diversified Automation

Leadec has completed the acquisition of Diversified Automation, Inc.

Learn more
SKIOLD A/S has acquired Rotecna S.A.U.
Private Equity | Agriculture

SKIOLD A/S has acquired Rotecna S.A.U.

Combining SKIOLD and Rotecna delivers clear strategic benefits to both companies, including a stronger global footprint and an enhanced platform to grow in new markets, a broader product portfolio of leading technologies and increased scale to support investments in R&D, such as digital solutions. Rotecna joins SKIOLD’s existing pig business unit, nearly doubling its size in terms of revenue. With this acquisition, SKIOLD Group’s revenue is approaching €200 million (US$235 million).

Learn more
“We are very grateful to Oakins for their support on this, behind the scenes, complex transaction. They have clearly proven their added value as they were able to quickly understand the essence of the business and structure the process in such a way that it benefited us, but also prospective acquirors. Throughout the process, the Oaklins team has proven to be a dedicated and knowledgeable partner to us.”

Hugo de Bruin

Partner, Gilde Healthcare Partners

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=FI&includes=featured_images,tags&language=en-FI&limit=1&tags=private-equity

Quarterly Highlights | Q4 2021

2021 ended up being a year with record M&A activity despite many concerns that the COVID-19 pandemic would significantly impact the global M&A market for the worse. Faced with such buoyant demand and competition, the need for meaningful information and support among businesses is greater than ever. Discover how our global team has collaborated closely across the borders, helping entrepreneurs and companies reach their full potential.

Learn more

Talk to our local advisors

 Marcus  Blomqvist

Marcus Blomqvist

Partner

Helsinki, Finland
Oaklins Finland

Meet our global industry specialists

 Hadrien  Mollard

Hadrien Mollard

Managing Partner

Paris, France
Oaklins France
 Frank  de Hek

Frank de Hek

Partner

Amsterdam, Netherlands
Oaklins Netherlands
 José  Falgás

José Falgás

Partner

Madrid, Spain
Oaklins SOCIOS
 Brian  Livingston

Brian Livingston

Managing Director

London, United Kingdom
Oaklins Smith & Williamson
 Reed  Phillips

Reed Phillips

Managing Partner

New York, United States
Oaklins DeSilva+Phillips